SG EFF. CALL24 E2Z Share Price

Warrant

K8681

DE000SW74859

Real-time Bid/Ask 14:04:15 22/05/2024 BST
1.61 EUR / 1.68 EUR +0.92% Intraday chart for SG EFF. CALL24 E2Z
Current month+114.47%
1 month+181.03%
Date Price Change
21/05/24 1.63 +5.16%
20/05/24 1.55 +9.15%
17/05/24 1.42 +15.45%
16/05/24 1.23 0.00%
15/05/24 1.23 0.00%

Delayed Quote BME

Last update May 21, 2024 at 04:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ALMIRALL, S.A.
IssuerLogo Issuer Société Générale Société Générale
K8681
ISINDE000SW74859
Date issued 28/03/2024
Maturity 21/06/2024 (30 Days)
Parity 1 : 1
Emission price 0.52
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.63
Lowest since issue 0.52
Spread 0.07
Spread %4.17%

Company Profile

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Sector
-
More about the company

Ratings for Almirall, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Almirall, S.A.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
9.515 EUR
Average target price
11.28 EUR
Spread / Average Target
+18.52%
Consensus
  1. Stock Market
  2. Warrants
  3. K8681 Warrant